echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Discussion on the implementation path of medical device registrant system under the background of MAH

    Discussion on the implementation path of medical device registrant system under the background of MAH

    • Last Update: 2021-03-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The background and development history of the medical device MAH system

    The background and development history of the medical device MAH system

    With reference to the advantages of the drug MAH system in developed countries such as Europe and the United States, in August 2015, the State Council issued the "Opinions on Reforming the Drug and Medical Device Review and Approval System", proposing to promote the drug marketing authorizer system.


    Figure 1 The development history of the medical device MAH system

    According to public information

    two,

    two,

    The impact of the implementation of the medical device MAH system and development opportunities

    The impact of the implementation of the medical device MAH system and development opportunities

    Before the implementation of the medical device MAH system, medical device companies must apply for a product registration certificate before they can apply for a production license.


    1.


    The MAH system will effectively encourage the initiative, enthusiasm and creativity of R&D companies, researchers, and clinical institutions, and stimulate more R&D companies and researchers to engage in innovative R&D.


    2.


    According to the Firestone Creation database, as of March 13, 2021, there are 22,384 domestic medical device manufacturing and R&D enterprises, of which more than 90% are small and medium-sized enterprises, and less than 10% of enterprises above designated size.


    The launch of the medical device MAH can effectively solve the problems of limited funds, compliance, lack of production personnel, and long new workshop cycles faced by start-ups in the early stage, allowing innovative R&D companies to focus on product development and do not need to obtain mass production after registration Too much financial and management energy is invested in manufacturing, and it can be quickly produced and marketed through OEM or outsourcing, shortening the listing cycle of enterprise products.


    3.


    The registrant system can avoid the situation of multiple licenses and multiple competitions for the same variety, and it will be more flexible for mergers and acquisitions and reorganizations of enterprises, and the cooperation model will also be more diverse.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.